Suppr超能文献

缓释美托洛尔和阿替洛尔后最大运动表现的代谢方面

Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.

作者信息

Folgering H T, Borm J F, van Haaren R H

出版信息

Eur J Clin Pharmacol. 1982 Oct;23(4):283-8. doi: 10.1007/BF00613607.

Abstract

Maximal exercise performance by eight healthy male subjects was tested after one week of medication with slow-release metoprolol 200 mg/d (metoprolol-SR), atenolol 200 mg/d or placebo, in a double blind crossover trial. The maximal working capacity was significantly decreased after atenolol and metoprolol-SR. Plasma glucose and FFA concentrations during the exercise test did not change: either after placebo therapy or after beta-blockade. The anerobic threshold did not change after beta-blockade, but the changes in lactate due to the exercise were less after beta-blockade. Neither beta-blocker affected the exercise-induced alteration in airway resistance. Both drugs caused a small but significant ventilatory depression at rest and at 75% of maximal exercise. It is concluded that the limiting factor in maximal exercise performance after beta 1-adrenergic blockade does not lie in oxygen transport to the working muscles via ventilation and the circulation, but is most probably due to anaerobic metabolism.

摘要

在一项双盲交叉试验中,8名健康男性受试者在服用200毫克/天的缓释美托洛尔(美托洛尔缓释片)、200毫克/天的阿替洛尔或安慰剂一周后,测试了其最大运动能力。服用阿替洛尔和美托洛尔缓释片后,最大工作能力显著下降。运动测试期间的血浆葡萄糖和游离脂肪酸浓度没有变化:无论是在安慰剂治疗后还是在β受体阻滞剂治疗后。β受体阻滞剂治疗后无氧阈值没有变化,但β受体阻滞剂治疗后运动引起的乳酸变化较小。两种β受体阻滞剂均未影响运动引起的气道阻力变化。两种药物在静息状态和最大运动的75%时均引起轻微但显著的通气抑制。结论是,β1肾上腺素能阻滞剂治疗后最大运动能力的限制因素不在于通过通气和循环向工作肌肉输送氧气,而很可能是由于无氧代谢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验